{"id":731,"date":"2015-05-12T18:11:24","date_gmt":"2015-05-12T18:11:24","guid":{"rendered":"https:\/\/www.cgs-cls.cz\/?page_id=731"},"modified":"2025-02-10T11:56:15","modified_gmt":"2025-02-10T10:56:15","slug":"pristrojove-a-farmaceuticke-novinky","status":"publish","type":"page","link":"https:\/\/www.cgs-cls.cz\/pristrojove-a-farmaceuticke-novinky\/","title":{"rendered":"P\u0159\u00edstrojov\u00e9 a farmaceutick\u00e9 novinky"},"content":{"rendered":"<p><a href=\"http:\/\/www.lipidica.cz\" rel=\"attachment wp-att-8895\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full image-8895\" src=\"https:\/\/www.cgs-cls.cz\/wp-content\/uploads\/2025\/02\/image0011.png\" alt=\"image001(1)\" width=\"250\" height=\"81\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Studie Lipidica \u2013 v\u010dasn\u00fd z\u00e1chyt n\u00e1dor\u016f slinivky b\u0159i\u0161n\u00ed<\/strong><\/p>\n<p>Studie funk\u010dn\u00ed zp\u016fsobilosti dle na\u0159\u00edzen\u00ed IVDR s&nbsp;n\u00e1zvem \u201eStudie klinick\u00e9 funkce zdravotnick\u00e9ho prost\u0159edku-software \u201eLipidica 1.0\u201c zpracov\u00e1vaj\u00edc\u00edho data z&nbsp;lipidomick\u00e9 anal\u00fdzy pro screening n\u00e1dorov\u00fdch onemocn\u011bn\u00ed slinivky\u201c je zam\u011b\u0159ena na odhalen\u00ed n\u00e1dor\u016f slinivky b\u0159i\u0161n\u00ed ji\u017e v&nbsp;rann\u00fdch operabiln\u00edch st\u00e1di\u00edch tohoto onemocn\u011bn\u00ed, kdy je mo\u017en\u00e1 \u00fa\u010dinn\u00e1 l\u00e9\u010dba.<br \/>\nJedn\u00e1 se o prospektivn\u00ed multicentrickou nerandomizovanou klinickou studii se dv\u011bma rameny, kter\u00e1 je registrov\u00e1na na clinicaltrials.gov pod \u010d\u00edslem NCT06549725.<br \/>\nStudie byla schv\u00e1lena St\u00e1tn\u00edm \u00fastavem pro kontrolu l\u00e9\u010div a etick\u00fdmi komisemi zdravotnick\u00fdch za\u0159\u00edzen\u00ed, ve kter\u00fdch prob\u00edh\u00e1. Je realizov\u00e1na pod z\u00e1\u0161titou \u010cGS \u010cLS JEP.<br \/>\nPrim\u00e1rn\u00edm c\u00edlem studie je verifikovat, \u017ee testovan\u00fd software dovede rozli\u0161ovat mezi pacienty s&nbsp;diagnostikovan\u00fdm n\u00e1dorem slinivky b\u0159i\u0161n\u00ed v&nbsp;resekabiln\u00edm st\u00e1diu a osobami bez t\u00e9to diagn\u00f3zy, av\u0161ak ve vy\u0161\u0161\u00edm riziku z&nbsp;d\u016fvodu genetick\u00fdch predispozic a rodinn\u00e9 anamn\u00e9zy.<br \/>\nStudie bude prob\u00edhat b\u011bhem n\u00e1sleduj\u00edc\u00edch 3 let, celkov\u00e1 studijn\u00ed populace je 419 subjekt\u016f.<br \/>\n<strong>Zadavatel:<\/strong><br \/>\nLipidica, a.s.<br \/>\n<strong>N\u00e1rodn\u00ed medic\u00ednsk\u00fd koordin\u00e1tor:<\/strong><br \/>\ndoc. MUDr. Jan Trna, Ph.D., Masaryk\u016fv onkologick\u00fd \u00fastav<br \/>\nManagement studie: CZECRIN L\u00e9ka\u0159sk\u00e1 fakulta Masarykovy Univerzity<br \/>\n<strong>\u00da\u010dast ve studii:<\/strong><br \/>\nDo studie mohou b\u00fdt za\u0159azeni pacienti s&nbsp;nov\u011b diagnostikovan\u00fdm resekabiln\u00edm n\u00e1dorem\/karcinomem (rameno 1) a d\u00e1le osoby se zv\u00fd\u0161en\u00fdm rizikem vzniku n\u00e1dor\u016f slinivky b\u0159i\u0161n\u00ed (rameno 2).<br \/>\n<strong>Za\u0159azovac\u00ed krit\u00e9ria:<\/strong><\/p>\n<p><a href=\"https:\/\/www.cgs-cls.cz\/wp-content\/uploads\/2025\/02\/tabulka_cgs.png\" rel=\"attachment wp-att-8884\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.cgs-cls.cz\/wp-content\/uploads\/2025\/02\/tabulka_cgs.png\" alt=\"tabulka cgs\" width=\"527\" height=\"811\" \/><\/a><\/p>\n<p>V\u00edce informac\u00ed o studii Lipidica naleznete na: <a href=\"http:\/\/www.lipidica.cz\">www.lipidica.cz<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; Studie Lipidica \u2013 v\u010dasn\u00fd z\u00e1chyt n\u00e1dor\u016f slinivky b\u0159i\u0161n\u00ed Studie funk\u010dn\u00ed zp\u016fsobilosti dle na\u0159\u00edzen\u00ed IVDR s&nbsp;n\u00e1zvem \u201eStudie klinick\u00e9 funkce zdravotnick\u00e9ho prost\u0159edku-software \u201eLipidica 1.0\u201c zpracov\u00e1vaj\u00edc\u00edho data z&nbsp;lipidomick\u00e9 anal\u00fdzy pro screening n\u00e1dorov\u00fdch onemocn\u011bn\u00ed slinivky\u201c je zam\u011b\u0159ena na odhalen\u00ed n\u00e1dor\u016f slinivky b\u0159i\u0161n\u00ed ji\u017e v&nbsp;rann\u00fdch operabiln\u00edch st\u00e1di\u00edch tohoto onemocn\u011bn\u00ed, kdy je mo\u017en\u00e1 \u00fa\u010dinn\u00e1 l\u00e9\u010dba. Jedn\u00e1 se o prospektivn\u00ed <a class=\"read-more\" href=\"https:\/\/www.cgs-cls.cz\/pristrojove-a-farmaceuticke-novinky\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":87,"ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-731","page","type-page","status-publish","hentry"],"acf":[],"lang":"cs","translations":{"cs":731},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.cgs-cls.cz\/api\/wp\/v2\/pages\/731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cgs-cls.cz\/api\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cgs-cls.cz\/api\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cgs-cls.cz\/api\/wp\/v2\/users\/1"}],"version-history":[{"count":20,"href":"https:\/\/www.cgs-cls.cz\/api\/wp\/v2\/pages\/731\/revisions"}],"predecessor-version":[{"id":8934,"href":"https:\/\/www.cgs-cls.cz\/api\/wp\/v2\/pages\/731\/revisions\/8934"}],"wp:attachment":[{"href":"https:\/\/www.cgs-cls.cz\/api\/wp\/v2\/media?parent=731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}